Результати пошуку - Rienk E. Jeeninga

  • Показ 1 - 11 результатів із 11
Уточнити результати
  1. 1
    Proteomic Studies Reveal Coordinated Changes in T-Cell Expression Patterns upon Infection with Human Immunodeficiency Virus Type 1

    Proteomic Studies Reveal Coordinated Changes in T-Cell Expression Patterns upon Infection with Human Immunodeficiency Virus Type 1 за авторством Jeffrey H. Ringrose, Rienk E. Jeeninga, Ben Berkhout, Dave Speijer

    Опубліковано 2008
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G

    Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G за авторством Rienk E. Jeeninga, Maarten Hoogenkamp, Mercedes Armand‐Ugón, Michel de Baar, Koen Verhoef, Ben Berkhout

    Опубліковано 2000
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors

    Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors за авторством Julia J.M. Eekels, Sophie Sagnier, Dirk Geerts, Rienk E. Jeeninga, Martine Biard‐Piechaczyk, Ben Berkhout

    Опубліковано 2012
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Human Immunodeficiency Virus Type 1 Subtypes Have a Distinct Long Terminal Repeat That Determines the Replication Rate in a Host-Cell-Specific Manner

    Human Immunodeficiency Virus Type 1 Subtypes Have a Distinct Long Terminal Repeat That Determines the Replication Rate in a Host-Cell-Specific Manner за авторством Tim van Opijnen, Rienk E. Jeeninga, Maarten C. Boerlijst, Georgios Pollakis, Veera Zetterberg, Mika Salminen, Ben Berkhout

    Опубліковано 2004
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    ViroSpot microneutralization assay for antigenic characterization of human influenza viruses

    ViroSpot microneutralization assay for antigenic characterization of human influenza viruses за авторством Carel A. van Baalen, Rienk E. Jeeninga, Germaine Penders, Brenda van Gent, Ruud van Beek, Marion Koopmans, Guus F. Rimmelzwaan

    Опубліковано 2016
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Emergence of the Virulence-Associated PB2 E627K Substitution in a Fatal Human Case of Highly Pathogenic Avian Influenza Virus A(H7N7) Infection as Determined by Illumina Ultra-Deep Sequencing

    Emergence of the Virulence-Associated PB2 E627K Substitution in a Fatal Human Case of Highly Pathogenic Avian Influenza Virus A(H7N7) Infection as Determined by Illumina Ultra-Deep... за авторством Marcel Jonges, Matthijs R. A. Welkers, Rienk E. Jeeninga, Adam Meijer, Peter M. Schneeberger, Ron A. M. Fouchier, Menno D. de Jong, Marion Koopmans

    Опубліковано 2013
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study

    Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study за авторством Ellie Hershberger, Susan Sloan, Kristin Narayan, Catherine A. Hay, Patrick F. Smith, Frank Engler, Rienk E. Jeeninga, Saskia L. Smits, José Trevejo, Zach Shriver, David Oldach

    Опубліковано 2019
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    An AP-1 Binding Site in the Enhancer/Core Element of the HIV-1 Promoter Controls the Ability of HIV-1 To Establish Latent Infection

    An AP-1 Binding Site in the Enhancer/Core Element of the HIV-1 Promoter Controls the Ability of HIV-1 To Establish Latent Infection за авторством Alexandra Duverger, Frank Wolschendorf, Mingce Zhang, Fredric Wagner, Brandon Hatcher, Jennifer Jones, Randy Q. Cron, Renée M. van der Sluis, Rienk E. Jeeninga, Ben Berkhout, Olaf Kutsch

    Опубліковано 2012
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Identification of a New Cyclovirus in Cerebrospinal Fluid of Patients with Acute Central Nervous System Infections

    Identification of a New Cyclovirus in Cerebrospinal Fluid of Patients with Acute Central Nervous System Infections за авторством Le Van Tan, H. Rogier van Doorn, Ho Dang Trung Nghia, Tran Thi Hong Chau, Le Thi Phuong Tu, Michèl de Vries, Marta Canuti, Martin Deijs, Maarten F. Jebbink, Stephen Baker, Juliet E. Bryant, Nguyễn Thị Thắm, Chinh Bkrong Nguyen, Maciej F. Boni, Tran Quoc Loi, Lê Thị Phượng, Joost T. P. Verhoeven, Martín Crusat, Rienk E. Jeeninga, Constance Schultsz, Nguyễn Văn Vĩnh Châu, Tran Tinh Hien, Lia van der Hoek, Jeremy Farrar, Menno D. de Jong

    Опубліковано 2013
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report

    Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report за авторством Irina Meln, Victor M. Cnossen, Nicoletta Corti, Arno C. Andeweg, Marc Baay, Christopher Chiu, John Coia, Oliver A. Cornely, Rebecca Jane Cox, Dileep Dasyam, Sigrid C. J. De Keersmaecker, M. Elen Deming, Joanna Waldock, Othmar G. Engelhardt, Manman Guo, Okba Haj-Ali Saflo, Annefleur D.O. Hensen, Rienk E. Jeeninga, Simon Kolstoe, Oleg Krut, Ed J. Kuijper, Lorna Leal, Natalie I Mazur, Kristin Greve-Isdahl Mohn, Sandra Morel, Ab Osterhaus, Ana Moreira, Wiep Klaas Smits, Saranya Sridhar, Danny Toomey, Joop van Gerven, Maria J. G. T. Vehreschild, Juan Pablo Yarzábal, Paul Zimmer-Harwood, Pieter Neels, Ole F. Olesen, Meta Roestenberg, Ingrid M. C. Kamerling

    Опубліковано 2025
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis

    Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis за авторством Mark Manak, Luc Gagnon, Steven Phay-Tran, Philipa Levesque-Damphousse, Aymeric Fabie, Matthieu Daugan, S. Khan, Pamela C. Proud, Bethan Hussey, Daniel Knott, Sue Charlton, Bassam Hallis, Guruprasad R. Medigeshi, Neha Garg, Anbalagan Anantharaj, Rubhana Raqib, Protim Sarker, Mohammad Mamun Alam, Mustafizur Rahman, Marta G. Murreddu, Angela Balgobind, Rick Hofman, Silvia Grappi, Rosa Coluccio, Pierpaolo Calandro, Emanuele Montomoli, Giada Mattiuzzo, Sandra Prior, Yann Le Duff, Mark Page, Jane A. Mitchell, Lauren M. Schwartz, Yannic C. Bartsch, Ali Azizi, Valentina Bernasconi, Vijay Zala, Ana Paula de Almeida, Helen Fassoulas, Tanvi Agrawal, Janmejay Singh, Anjan Kumar Roy, Saskia C. Berndsen, M. Mooij, Hester Buitendijk, Coen A.L. Stalpers, Modou Jarju, Filippo Battistella, Rienk E. Jeeninga, Daniël Duijsings, Ilaria Razzano, Eleonora Molesti, Livia Mazzini, Adele Boccuto, Angela Holder, Edward Mee, Matthew F. D. Hurley, Jennifer Padley, Nicola J. Rose, Trina Gorman, Jose Vila-Belda, Hannah James, Jerome Carless

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: